Showing results (311-320 of 466) with videos related to

Sort By:
Pageof 47
Blood|February 2, 2024
Management of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Blood|January 31, 2024
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Bone Marrow Transplantation|January 16, 2013
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation studyP G Medd, A J Peniket, T J Littlewood, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
Clinical Therapeutics|July 18, 2003
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulationsJane P Barrett, Katerina A Vardulaki, Christopher Conlon, et al.
Bone Marrow Transplantation|November 3, 2015
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysisM L Riches, S Trifilio, M Chen, et al.
Ejhaem|July 18, 2022
Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patientsJohn Girdlestone, Meera Raymond, Bronwen Shaw, et al.
British Journal of Haematology|July 11, 2006
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation studyJennifer M Bird, Rhian Fuge, Bhawna Sirohi, et al.
Bone Marrow Transplantation|June 22, 2005
Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletionR J Garland, S J Groves, P Diamanti, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
Pageof 47